Document Information
Improving Anti-Drug Budgeting
The United States spends over $16 billion a year to fight drugs, or so the Director of the Office of National Drug Control Policy (ONDCP) has certified over the past few years. What confidence is there that this budget accurately reflects federal expenditures on antidrug activities? The agencies that compile the antidrug budgets use a variety of calculation methods, some of which are problematic. Although the drug-control budget will necessarily always be a collection of estimates, it can be significantly improved, by establishing common principles to guide the calculations and by basing them on empirical data. Such steps would provide ONDCP with the ability to implement strategies and hold agencies accountable for their performance. This is essential for the ONDCP Director to be able to direct and coordinate the nation's antidrug programs and for the American people to be confident about what resources are actually being spent on antidrug activities.
Support RAND Research — Buy This Product!
Paperback Cover Price: $15.00
Discounted Web Price: $13.50
Pages: 142
ISBN/EAN: 0-8330-2915-0
Free, downloadable PDF file(s) are available below.
RAND makes an electronic version of this document available for free as a public service. If you find this information valuable, please consider purchasing a paper copy of the full document to help support RAND research.
Use Adobe Acrobat Reader version 7.0 or higher for the best experience.
Contents
Preface PDF
Tables PDF
Summary PDF
Acknowledgments PDF
Abbreviations PDF
Chapter One:
Introduction PDF
Chapter Two:
Budgeting Overview PDF
Chapter Three:
U.S. Coast Guard PDF
Chapter Four:
Federal Bureau of Prisons PDF
Chapter Five:
U.S. Department of Defense PDF
Chapter Six:
Immigration and Naturalization Service PDF
Chapter Seven:
U.S. Customs Service PDF
Chapter Eight:
Federal Bureau of Investigation PDF
Chapter Nine:
Substance Abuse and Mental Health Services Administration PDF
Chapter Ten:
Department of Veterans Affairs PDF
Chapter Eleven:
Health Care Financing Administration PDF
Chapter Twelve:
U.S. Department of Education PDF
Chapter Thirteen:
Conclusions and Recommendations PDF
Bibliography PDF
The study was conducted within RAND's Science and Technology Division and RAND's Drug Policy Research Center.
The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit research organization providing objective analysis and effective solutions that address the challenges facing the public and private sectors around the world. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
* RAND research is conducted across divisions, centers, and projects; these organizational components are represented in the "Related RAND Divisions" section above.
Top
RAND® is a registered trademark. Copyright © 1994-2008 RAND Corporation. 